About FDA
-
-
Is the U.S. really slower than Europe in approving new drugs?
FDA answers this question with a series of charts and graphs that show that, on average, FDA has approved more novel new drugs, has approved these drugs more quickly, and has enabled these drugs to come to market sooner than has its European counterpart, the European Medicines Agency (EMA). Read the Answer. (PDF - 223KB)
Show all related FDA Basics Questions
- FDA Basics – OCTGT Webinar on Tissue Safety
- FDA Basics Metrics: August 2012
- FDA's Pesticide Program
- FDA Basics Webinar: FDA Office of Minority Health - Steps to Address Health Disparities
- FDA Basics Metrics: July 2012
- Recall Process for FDA-Regulated Products
- FDA Basics Metrics: June 2012
- FDA Basics Metrics: December 2011
- FDA Basics Metrics: May 2012
- FDA Basics Metrics: April 2012
- FDA Basics Metrics: January 2012
- FDA Basics Metrics: March 2012
- FDA Basics Metrics: February 2012
- Who should I contact about products not regulated by FDA?
- What doesn’t FDA regulate? How do I contact the agencies that do?
- What does FDA regulate?
- Connect with Us: Using FDAs Digital Tools to Present, Participate and Personalize Tobacco Information
- Where can I find information about adverse reactions to a medicine prescribed for my child?
- Where can I find information about medicines prescribed for my child?
- Materials from Webinar on Access to Investigational Drugs
- How can I be notified about new import alerts?
- Does FDA regulate these new powerful laser "pointers" and are they hazardous?
- May Webinar - Hearing Aids: The Basic Information You Need to Know
- FDA Basics Webinar: "Mini-Sentinel," FDA's New Tool for Monitoring the Safety of FDA-Approved Medical Products
- FDA Basic Video: Norman Baylor Discusses Vaccines (Video)
-
How helpful was this information?
-
?
-
-
